These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 38788248)

  • 1. Advancements in nanomedicine: Precision delivery strategies for male pelvic malignancies - Spotlight on prostate and colorectal cancer.
    Yang G; Cao Y; Yang X; Cui T; Tan NZV; Lim YK; Fu Y; Cao X; Bhandari A; Enikeev M; Efetov S; Balaban V; He M
    Exp Mol Pathol; 2024 Jun; 137():104904. PubMed ID: 38788248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Potential of Nanomedicine in Prostate Cancer Immunotherapy: Breakthroughs and Prospects.
    Jiang Y; Wang C; Zu C; Rong X; Yu Q; Jiang J
    Int J Nanomedicine; 2024; 19():9459-9486. PubMed ID: 39371481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unleashing novel horizons in advanced prostate cancer treatment: investigating the potential of prostate specific membrane antigen-targeted nanomedicine-based combination therapy.
    He M; Cao Y; Chi C; Zhao J; Chong E; Chin KXC; Tan NZV; Dmitry K; Yang G; Yang X; Hu K; Enikeev M
    Front Immunol; 2023; 14():1265751. PubMed ID: 37795091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology Advances in the Detection and Treatment of Lymphoid Malignancies.
    Adamo FM; De Falco F; Dorillo E; Sorcini D; Stella A; Esposito A; Arcaleni R; Rosati E; Sportoletti P
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
    Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
    Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle therapeutics for prostate cancer treatment.
    Sanna V; Sechi M
    Nanomedicine; 2012 Sep; 8 Suppl 1():S31-6. PubMed ID: 22640911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology in medicine revolutionizing drug delivery for cancer and viral infection treatments.
    Karahmet Sher E; Alebić M; Marković Boras M; Boškailo E; Karahmet Farhat E; Karahmet A; Pavlović B; Sher F; Lekić L
    Int J Pharm; 2024 Jul; 660():124345. PubMed ID: 38885775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface engineered multifunctional nano-systems for localised drug delivery against thyroid cancer: A review of current practices.
    Zhang Y; Tang N; Zhou H; Zhu Y
    Biomed Pharmacother; 2024 Jul; 176():116840. PubMed ID: 38820975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy.
    Gautam RK; Mittal P; Goyal R; Dua K; Mishra DK; Sharma S; Singla RK
    Curr Med Chem; 2024; 31(28):4479-4494. PubMed ID: 37828674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Nanotechnology-based Therapeutics: A New Insight into Promising Drug Delivery System for Lung Cancer Therapy.
    Verma R; Rao L; Nagpal D; Yadav M; Kumar V; Kumar V; Kumar H; Parashar J; Bansal N; Kumar M; Pandey P; Mittal V; Kaushik D
    Recent Pat Nanotechnol; 2024; 18(4):395-414. PubMed ID: 37537775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current prospects and challenges of nanomedicine delivery in prostate cancer therapy.
    Gupta S; Gupta PK; Dharanivasan G; Verma RS
    Nanomedicine (Lond); 2017 Dec; 12(23):2675-2692. PubMed ID: 29098929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
    Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
    Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology and curcumin: a novel and promising approach in digestive cancer therapy.
    Zhang Y; Li Z; Huang Y; Xu Y; Zou B
    Nanomedicine (Lond); 2023 Nov; 18(27):2081-2099. PubMed ID: 38078442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targetable Clinical Nanoparticles for Precision Cancer Therapy Based on Disease-Specific Molecular Inflection Points.
    Kaittanis C; Bolaender A; Yoo B; Shah N; Ouerfelli O; Grimm J
    Nano Lett; 2017 Nov; 17(11):7160-7168. PubMed ID: 29035540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new era of pancreatic cancer treatment: Application of nanotechnology breaking through bottlenecks.
    Luo W; Zhang T
    Cancer Lett; 2024 Jul; 594():216979. PubMed ID: 38795762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine and its applications to the treatment of prostate cancer.
    Ouvinha de Oliveira R; de Santa Maria LC; Barratt G
    Ann Pharm Fr; 2014 Sep; 72(5):303-16. PubMed ID: 25220226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
    Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
    Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
    Kateb B; Chiu K; Black KL; Yamamoto V; Khalsa B; Ljubimova JY; Ding H; Patil R; Portilla-Arias JA; Modo M; Moore DF; Farahani K; Okun MS; Prakash N; Neman J; Ahdoot D; Grundfest W; Nikzad S; Heiss JD
    Neuroimage; 2011 Jan; 54 Suppl 1(Suppl 1):S106-24. PubMed ID: 20149882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theranostic applications of peptide-based nanoformulations for growth factor defective cancers.
    Ghosh A; Maske P; Patel V; Dubey J; Aniket K; Srivastava R
    Int J Biol Macromol; 2024 Mar; 260(Pt 2):129151. PubMed ID: 38181914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.